The Carlyle Group Top Holdings and 13F Report (2022) About The Carlyle GroupThe Carlyle Group NASDAQ: CG has filed 13-F forms with the SEC as an investor. The Carlyle Group is itself a publicly traded company. For more information on The Carlyle Group stock, visit the The Carlyle Group stock profile here.Investment ActivityThe Carlyle Group has $3.80 billion in total holdings as of September 30, 2022.The Carlyle Group owns shares of 23 different stocks, but just 1 company or ETF makes up 80% of its holdings.Approximately 89.42% of the portfolio was purchased this quarter.About 1.12% of the portfolio was sold this quarter.This quarter, The Carlyle Group has purchased 27 new stocks and bought additional shares in 1 stock.The Carlyle Group sold shares of 5 stocks and completely divested from 4 stocks this quarter.Largest Holdings Standardaero Inc $3,579,159,391Soleno Therapeutics $61,448,143Weride Inc $46,450,418Phathom Pharmaceuticals $21,924,986Pony Ai Inc $20,836,783 Largest Purchases this Quarter Standardaero Inc 127,676,968 shares (about $3.40B) Largest Sales this Quarter Soleno Therapeutics 514,666 shares (about $36.73M)Getty Images 2,450,347 shares (about $4.24M)Smart Share Global 447,280 shares (about $500.95K)Maplebear Inc 2,740 shares (about $109.30K)Complete Solaria Inc 111 shares (about $172.05) Sector Allocation Over TimeMap of 500 Largest Holdings ofThe Carlyle Group Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorStandardaero Inc$3,579,159,391$3,401,314,427 ▲1,912.5%134,352,83094.1%ComSLNOSoleno Therapeutics$61,448,143$36,731,713 ▼-37.4%860,9801.6%MedicalWeride Inc$46,450,4180.0%3,423,0231.2%Sponsored AdsPHATPhathom Pharmaceuticals$21,924,9860.0%3,496,8080.6%MedicalPony Ai Inc$20,836,7830.0%2,362,4470.5%Sponsored AdsINVHInvitation Homes$16,640,8750.0%477,5000.4%FinanceGETYGetty Images$10,785,256$4,239,100 ▼-28.2%6,234,2520.3%Computer and TechnologyCUBECubeSmart$9,417,5550.0%220,5000.2%FinanceSMHISEACOR Marine$6,860,1510.0%1,355,7610.2%TransportationEMSmart Share Global$4,886,480$500,954 ▼-9.3%4,362,9290.1%Consumer DiscretionaryJasper Therapeutics Inc$4,584,6130.0%1,066,1890.1%Com NewExicure Inc$3,579,5940.0%281,6360.1%ComComplete Solaria Inc$3,075,987$172 ▼0.0%1,984,5080.1%ComFWRDForward Air$2,673,7230.0%107,2140.1%TransportationHLVXHilleVax$2,647,4200.0%1,838,4860.1%MedicalACETAdicet Bio$2,276,7050.0%2,948,7180.1%MedicalQ32 Bio Inc$1,808,4950.0%1,102,7410.0%ComDNUTKrispy Kreme$1,676,4800.0%340,7480.0%Consumer StaplesOnkure Therapeutics Inc$1,160,5490.0%269,8950.0%Com Cl ASPRBSpruce Biosciences$840,2800.0%2,896,5180.0%MedicalNABLN-able$664,5600.0%93,7320.0%Business ServicesMaplebear Inc$218,557$109,298 ▼-33.3%5,4790.0%ComNucana Plc$116,0000.0%133,3330.0%Sponsored AdrREPXRiley Exploration Permian$0$315,341 ▼-100.0%00.0%EnergyHOODRobinhood Markets$0$232,577 ▼-100.0%00.0%FinanceSpyre Therapeutics Inc$0$223,761 ▼-100.0%00.0%Com NewMETCRamaco Resources$0$200,777 ▼-100.0%00.0%EnergyShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
